- Doth AH, Hansson PT, Jensen MP, Taylor RS (2010) The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain 149:338–44. https://doi.org/10.1016/j.pain.2010.02.034 [CrossRef] [PubMed] [Google Scholar]
- Attal N, Lantéri-Minet M, Laurent B, et al (2011) The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 152:2836–43. https://doi.org/10.1016/j.pain.2011.09.014 [CrossRef] [PubMed] [Google Scholar]
- Langley PC, Van Litsenburg C, Cappelleri JC, Carroll D (2013) The burden associated with neuropathic pain in Western Europe. J Med Econ 16:85–95. https://doi.org/10.3111/13696998.2012.729548 [CrossRef] [PubMed] [Google Scholar]
- Colloca L, Ludman T, Bouhassira D, et al (2017) Neuropathic pain. Nat Rev Dis Primer 3:17002. https://doi.org/10.1038/nrdp.2017.2 [CrossRef] [Google Scholar]
- Dworkin RH, Malone DC, Panarites CJ, et al (2010) Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. J Pain 11:360–8. https://doi.org/10.1016/j.jpain.2009.08.005 [Google Scholar]
- Bouhassira D, Letanoux M, Hartemann A (2013) Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study. PloS One 8:e74195. https://doi.org/10.1371/journal.pone.0074195 [CrossRef] [PubMed] [Google Scholar]
- Piano V, Lantéri-Minet M, Steegers M, et al (2013) A case vignette study to assess the knowledge of pain physicians of neuropathic cancer pain: room for improvement. Pain Physician 16: E779–E88 [PubMed] [Google Scholar]
- Torrance N, Ferguson JA, Afolabi E, et al (2013) Neuropathic pain in the community: more under-treated than refractory? Pain 154:690–9. https://doi.org/10.1016/j.pain.2012.12.022 [CrossRef] [PubMed] [Google Scholar]
- Martinez V, Attal N, Vanzo B, et al (2014) Adherence of French GPs to chronic neuropathic pain clinical guidelines: results of a cross-sectional, randomized, “e” case-vignette survey. PloS One 9:e93855. https://doi.org/10.1371/journal.pone.0093855 [CrossRef] [PubMed] [Google Scholar]
- Heutink M, Post MWM, Wollaars MM, van Asbeck FWA (2011) Chronic spinal cord injury pain: pharmacological and nonpharmacological treatments and treatment effectiveness. Disabil Rehabil 33:433–40. https://doi.org/10.3109/09638288.2010.498557 [CrossRef] [PubMed] [Google Scholar]
- Tamburin S, Lacerenza MR, Castelnuovo G, et al (2016) Pharmacological and non-pharmacological strategies in the integrated treatment of pain in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. Eur J Phys Rehabil Med 52:741–52 [PubMed] [Google Scholar]
- Martinez V, Attal N, Bouhassira D, Lantéri-Minet M (2010) Les douleurs neuropathiques chroniques : diagnostic, évaluation et traitement en médecine ambulatoire. Recommandations pour la pratique clinique de la Société française d’étude et de traitement de la douleur. Douleurs : Évaluation - Diagnostic - Traitement 11:3–21. https://doi.org/10.1016/j.douler.2009.12.009 [CrossRef] [Google Scholar]
- Finnerup NB, Attal N, Haroutounian S, et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–73. https://doi.org/10.1016/S1474-4422(14)70251-0 [CrossRef] [PubMed] [Google Scholar]
- Dworkin RH, O’Connor AB, Kent J, et al (2013) Interventional management of neuropathic pain: NeuPSIG recommendations. Pain 154:2249–61. https://doi.org/10.1016/j.pain.2013.06.004 [CrossRef] [PubMed] [Google Scholar]
- Cruccu G, Garcia-Larrea L, Hansson P, et al (2016) EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol 23:1489–99. https://doi.org/10.1111/ene.13103 [CrossRef] [PubMed] [Google Scholar]
- AFFSAPS (2009) Prise en charge médicamenteuse de la douleur aiguë et chronique chez l’enfant [Google Scholar]
- Moisset X, Bouhassira D, Avez Couturier J, et al (2020) Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol (Paris) 176:325–52 https://doi.org/10.1016/j.neurol.2020.01.361 [CrossRef] [PubMed] [Google Scholar]
- Guyatt GH, Oxman AD, Vist GE, et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–6. https://doi.org/10.1136/bmj.39489.470347.AD [Google Scholar]
- Balshem H, Helfand M, Schünemann HJ, et al (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–6. https://doi.org/10.1016/j.jclinepi.2010.07.015 [CrossRef] [PubMed] [Google Scholar]
- Bendtsen L, Zakrzewska JM, Abbott J, et al (2019) EAN guideline on trigeminal neuralgia. Eur J Neurol 26(6) :831-49 https://doi.org/10.1111/ene.13950 [CrossRef] [PubMed] [Google Scholar]
- Heutink M, Post MW, Luthart P, et al (2014) Long-term outcomes of a multidisciplinary cognitive behavioural programme for coping with chronic neuropathic spinal cord injury pain. J Rehabil Med 46:540–5. https://doi.org/10.2340/16501977-1798 [CrossRef] [PubMed] [Google Scholar]
- Brown S, Johnston B, Amaria K, et al (2016) A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand J Pain 13:156–63. https://doi.org/10.1016/j.sjpain.2016.05.039 [CrossRef] [PubMed] [Google Scholar]
- Pickering G, Voute M, Macian N, et al (2019) Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial. Pain 160:1186–95. https://doi.org/10.1097/j.pain.0000000000001502 [CrossRef] [PubMed] [Google Scholar]
- Demant DT, Lund K, Finnerup NB, et al (2015) Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomized, double-blind, and placebo-controlled, phenotype panel study. Pain 156:2234–44. https://doi.org/10.1097/j.pain.0000000000000266 [CrossRef] [PubMed] [Google Scholar]
- Finnerup NB, Haroutounian S, Baron R, et al (2018) Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy. Pain 159:2339–46. https://doi.org/10.1097/j.pain.0000000000001340 [CrossRef] [PubMed] [Google Scholar]
- Robertson K, Marshman LAG, Plummer D, Downs E (2019) Effect of gabapentin vs. pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. JAMA Neurol 76:28–34. https://doi.org/10.1001/jamaneurol.2018.3077 [Google Scholar]
- Driot D, Jouanjus E, Oustric S, et al (2019) Patterns of gabapentin and pregabalin use and misuse: results of a population-based cohort study in France. Br J Clin Pharmacol 85:1260–9. https://doi.org/10.1111/bcp.13892 [CrossRef] [PubMed] [Google Scholar]
- Attal N, de Andrade DC, Adam F, et al (2016) Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 15:555–65. https://doi.org/10.1016/S1474-4422(16)00017-X [CrossRef] [PubMed] [Google Scholar]
- Ghasemi M, Ansari M, Basiri K, Shaigannejad V (2014) The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy. J Res Med Sci 19:106–11 [PubMed] [Google Scholar]
- Han ZA, Song DH, Oh HM, Chung ME (2016) Botulinum toxin type A for neuropathic pain in patients with spinal cord injury. Ann Neurol 79:569–78. https://doi.org/10.1002/ana.24605 [CrossRef] [PubMed] [Google Scholar]
- Derry S, Rice AS, Cole P, et al (2017) Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 1:CD007393. https://doi.org/10.1002/14651858.CD007393.pub4 [PubMed] [Google Scholar]
- Bouvenot G, Juillet Y, Saint-Pierre A, Serre MP (2018) Les prescriptions médicamenteuses hors AMM (autorisation de mise sur le marché) en France. Une clarification est indispensable. Bull Acad Natl Med 202:1749–82. https://doi.org/10.1016/S0001-4079(19)30181-5 [Google Scholar]
- Chenaf C, Kaboré JL, Delorme J, et al (2019) Prescription opioid analgesic use in France: Trends and impact on morbidity–mortality. Eur J Pain Lond Engl 23:124–34. https://doi.org/10.1002/ejp.1291 [CrossRef] [PubMed] [Google Scholar]
- Moisset X, Trouvin AP, Tran VT, et al (2016) Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain. Presse Med Paris Fr 45:447–62. https://doi.org/10.1016/j.lpm.2016.02.014 [Google Scholar]
- Miotto K, Cho AK, Khalil MA, et al (2017) Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg 124:44–51. https://doi.org/10.1213/ANE.0000000000001683 [CrossRef] [PubMed] [Google Scholar]
- ANSM (2019) État des lieux de la consommation des antalgiques opioïdes et leurs usages problématiques. https://ansm.sante.fr/Sinformer/Points-d-information-Points-d-information/Antalgiquesopioides-l-ANSM-publie-un-etat-des-lieux-de-la-consommationen-France-Point-d-Information. Accessed 19 Jul 2019 [Google Scholar]
- Pickering G, Marcoux M, Chapiro S, et al (2016) An algorithm for neuropathic pain management in older people. Drugs Aging 33:575–83. https://doi.org/10.1007/s40266-016-0389-7 [Google Scholar]
Accès gratuit
| Numéro |
Douleur analg
Volume 33, Numéro 2, Juin 2020
|
|
|---|---|---|
| Page(s) | 101 - 112 | |
| Section | Recommandations / Recommendations | |
| DOI | https://doi.org/10.3166/dea-2020-0113 | |
| Publié en ligne | 4 octobre 2020 | |
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.